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Abstract
Cdt1, a protein critical for replication origin licensing in G1 phase is degraded during S phase but 
re-accumulates in G2 phase. We now demonstrate that human Cdt1 has a separable essential 
mitotic function. Cdt1 localizes to kinetochores during mitosis through interaction with the Hec1 
component of the Ndc80 complex. G2-specific depletion of Cdt1 arrests cells in late prometaphase 
due to abnormally unstable kinetochore-microtubule (kMT) attachments and Mad1-dependent 
spindle assembly checkpoint activity. Cdt1 binds a unique loop extending from the rod domain of 
Hec1 that we show is also required for kMT attachment. Mutation of the loop domain prevents 
Cdt1 kinetochore localization and arrests cells in prometaphase. Super-resolution fluorescence 
microscopy indicates that Cdt1 binding to the Hec1 loop domain promotes a microtubule-
dependent conformational change in the Ndc80 complex in vivo. These results support the 
conclusion that Cdt1 binding to Hec1 is essential for an extended Ndc80 configuration and stable 
kinetochore microtubule attachment.
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The cell division cycle is the process of complete and precise duplication of the entire 
genome in S phase followed by accurate chromosome segregation in mitosis. The formation 
and stability of kinetochore-microtubule (kMT) attachments during mitosis depends on the 
Ndc80 complex, Ndc80 (hsHec1), Nuf2, Spc24 and Spc251, 2. Hec1/Nuf2 and Spc24/25 
form dimers respectively that are tethered together at the C-termini of Hec1/Nuf2 and the N-
termini of Spc24/Spc25 by long alpha helical coiled-coil rod domains. In the middle of the 
rod domain is a “hinge” site produced by a ~40 amino acid loop in Hec1 that is thought to 
play a key role in MT binding dynamics and attachment3. Binding partners for the loop 
region of yeast Hec1/Ndc80 proteins have been identified4, 5, but the partners and function 
of the unique Hec1 loop domain at metazoan kinetochores remains unknown. In this study, 
we identify the Cdt1 protein as an essential partner for Ndc80 dynamic function through 
interaction with the Hec1 loop domain.
Cdt1 is required for DNA replication origin licensing, the initial step in genome duplication, 
which occurs in G1 phase6, 7. Proteins involved in origin licensing are not strictly DNA 
replication factors however; some licensing proteins have functions in transcription8, 9, the 
DNA damage response10, 11, centrosome duplication12, and mitosis13, 14. We report here the 
previously undiscovered mitotic role for the Cdt1 replication licensing protein that is distinct 
from its role in DNA replication.
Results
Inhibition of Cdt1 function induces mitotic arrest
Both Cdc6 and Cdt1 proteins are required for replication licensing in human cells, but we 
found an intriguing difference in the phenotypes of Cdc6-depleted cells compared to Cdt1-
depleted cells. Cdc6-depleted cells arrest primarily in G1 as expected15, 16, but Cdt1-
depleted cells arrested in both G1 and G2/M, despite the fact that both proteins cooperate in 
the same DNA replication step, MCM loading (Fig. 1a). The accumulation of G2 cells 
suggested a possible unique mitotic role for Cdt1 which we set out to test.
To eliminate the possibility that a mitotic phenotype simply reflected replication errors in 
the preceding S phase, we took advantage of the fact that Cdt1 is actively degraded during S 
phase after its G1 origin licensing role is complete17 (Fig. 1b). We synchronized cells in 
early S phase, at which time origins are fully licensed, and released them into medium 
containing control siRNA or cdt1 siRNA. As expected, control cells had very low amounts 
of Cdt1 in S phase, and Cdt1 re-accumulated in G2 (Fig. 1c, lanes 1–5). Synchronized cells 
treated with cdt1 siRNA could not re-accumulate Cdt1 in G2 however (Fig. 1c, lanes 7–10). 
(Cdt1 is phosphorylated in G2 by stress MAP kinases17, 18) Cdt1 depletion during S phase 
caused no delay in S phase progression (Fig. S1a and S1b), and by 9 hours after release both 
control and Cdt1-depleted cells exhibited normal chromosome condensation and/or nuclear 
envelope breakdown (e.g. Figure 2a and data not shown). This unique experimental 
approach allowed us to generate cells that underwent a normal G1 and S phase but lacked 
Cdt1 during G2 and M phase.
We then tested the ability of Cdt1-depleted cells to transit mitosis to G1 after a nocodazole 
arrest and release (Fig. 1d and 1e). Control cells completed cell division, but Cdt1-depleted 
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cells remained arrested with G2 DNA content (Fig. 1e, si-control vs. si-cdt1). A cell line 
stably expressing normal Cdt1 with synonymous mutations in the siRNA target site was 
fully capable of mitotic progression (Fig. 1d and 1e). Unphosphorylatable Cdt118 also 
complemented the cell division phenotype of Cdt1-depleted cells (Fig. S1c and S1d). Cells 
depleted of Cdt1 during S phase did not accumulate phosphorylated H2AX by the 
subsequent G2, a marker of DNA damage, whereas siRNA transfection of asynchronous 
cultures to deplete either Cdt1 or another licensing protein, Orc6, resulted in the 
accumulation of phospho-H2AX-positive foci, presumably from incomplete replication and 
fork collapse (Figure S1e).
The majority of the synchronized Cdt1-depleted cells arrested just prior to metaphase with 
most chromosomes positioned near the spindle equator. A smaller fraction of cells arrested 
in prometaphase (Fig. 2a and 2b; Fig. S2a and S2b). In addition to Cdt1 depletion in 
synchronized cells, we also microinjected purified anti-Cdt1 antibody (Fig. S2c) into HeLa 
cells expressing GFP-tagged histone H2B during prophase or early prometaphase and 
conducted live imaging (n = 27). Anti-Cdt1 antibody induced both a severe delay in 
chromosome congression and an arrest near metaphase for the entire ~3 hr duration of 
imaging (Fig 2d and 2e). Control buffer-injected cells (n = 15) or control anti-mouse IgG-
injected cells (n = 8) executed mitosis normally (Fig. 2c, 2e and Supplementary Movies S1 
and S2). Anti-Cdt1 injection during late-prometaphase or metaphase (n = 10), resulted in 
70% of the cells remaining arrested in that stage for up to 8 hours. During this period, cells 
progressively lost chromosome alignment but did not divide (Fig. S2d, Movie S4).
Cdt1 localizes to mitotic kinetochores through interaction with the Hec1 component of 
Ndc80
The late prometaphase arrest of Cdt1-depleted cells prompted us to examine Cdt1 
localization in mitosis. Remarkably we detected endogenous Cdt1 co-localization with a 
known kinetochore protein, Hec1, in prometaphase in both nocodazole-treated PTK2 and 
HeLa cells (Fig. 3a, and data not shown). Cdt1 depletion by siRNA treatment in S phase 
eliminated detectable anti-Cdt1 kinetochore staining (Fig. S3a). We observed no kinetochore 
localization of the Cdt1 inhibitor geminin19, 20 at any stage of mitosis, (Fig. S3b). A second 
anti-Cdt1 antibody also detected endogenous Cdt1 at kinetochores in LLCPK1 cells (Fig. 
3b–3f). Thus, Cdt1 localizes to kinetochores in control cells at a time coincident with the 
stage at which Cdt1-depleted cells arrest.
In a search for Cdt1 interacting proteins by two-hybrid screening in yeast, we identified 
multiple independent clones containing portions of human Hec1 (Fig. S4a); the shortest 
contained Hec1 amino acids 306–642 (Fig. S4a and S4b). To determine if Cdt1 and Hec1 
interact biochemically, we incubated immobilized bacterially-expressed GST-Cdt1 with 
lysates of asynchronous HeLa cells. Endogenous Hec1 associated with GST-Cdt1 but not 
GST alone (Fig. 4a). Nuf2 was also retrieved from cell lysates by GST-Cdt1 (Fig. 4a) 
suggesting that Cdt1 can associate with the Ndc80 complex, possibly through a direct 
interaction with Hec1 (based on interaction of the fusions in yeast). We further confirmed 
the interaction between Cdt1 and Hec1 by reciprocal co-immunoprecipitation of the 
endogenous proteins (Fig. 4b and 4c).
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To test if Hec1 recruits Cdt1 to kinetochores in mitosis, we stained for endogenous Cdt1 in 
Hec1-depleted PTK2 cells. Hec1 depletion resulted in a profound loss of Cdt1 at 
kinetochores in nocodazole-treated prometaphase (Fig. 4d, bottom panel and Fig. 4e) and 
metaphase cells (Fig. S4c, bottom panel) compared to controls (Fig. 4d and S4c, top panels). 
We observed no Cdt1 decrease in extracts of Hec1-depleted cells (Fig. S4d), and Cdt1 
depletion had no effect on Hec1 expression or kinetochore localization (Fig. S4e). Other 
kinetochore proteins, including components of the Mis12 complex, Knl1, and the Zwint1-
RZZ complex, were also localized normally in Cdt1-depleted cells (Fig. 2a, S4e, S8a, and 
S8b).
Like Cdt1, ORC is essential for replication origin licensing, and the Orc2 and Orc6 subunits 
in particular have also been reported to localize to centromeres or kinetochores13, 14. ORC is 
required for Cdt1 chromatin localization in G121, and the Orc6 subunit associates with Cdt1 
(Fig. S5a22). We found that, like Cdt1, Orc6 immunofluorescence at kinetochores was also 
substantially reduced in Hec1-depleted cells (Fig. 4f and 4g). Orc6 depletion had no effect 
on Hec1 or Cdt1 kinetochore localization however (Fig. S5d and S5e). Interestingly, 
depletion of Cdt1 resulted in a ~50% decrease in the intensity of Orc6 kinetochore staining 
(Fig. S5b and S5c). To compare the reported mitotic defects induced by Orc6 inhibition14 to 
those produced by depleting Cdt1, we first calculated the mitotic indices of asynchronous 
cells depleted of Orc6. Orc6 is not degraded in S phase like Cdt1, so we could not employ 
the same synchronization strategy to remove Orc6 only before mitosis. Orc6 depletion 
caused a ~50% increase in the number of mitotic cells compared to controls (Fig. S5f) by 
producing a four-fold increase in the number of telophase cells (Fig. S5g). In addition, cells 
depleted of Orc6 exhibited normal cold-stable kMTs (Fig. S5h). These observations support 
the conclusion14, 23 that Orc6 has a role late in mitosis during cytokinesis distinct from the 
role of Cdt1 during prometaphase or metaphase.
The Hec1 loop domain is required for Cdt1 localization and anaphase onset
Our two-hybrid analysis indicated that the Cdt1-binding region of Hec1 includes a short 
interruption in the coiled-coil pattern postulated to be a flexible “loop”3 (Fig. S4a and 4b). 
To test if this domain is required for Cdt1 binding, we replaced the normal loop sequence 
with a sequence of alternative amino acids of similar length, which we term “Hec1 
LoopMUT” (Fig. 5a). A similar sequence provides a flexible linker in a well-studied GFP-
PCNA fusion24. Both wild type Hec1 (wt) and Hec1 LoopMUT were tagged with GFP at 
their C-termini. Strikingly, Hec1 LoopMUT-GFP failed to co-immunoprecipitate with Cdt1 
whereas wt Hec1-GFP bound Cdt1 readily (Fig. 5b, compare lanes 4 and 5). Both GFP-
tagged wt and LoopMUT localized normally in PTK2 and HeLa cells (Fig. 5c and 5e). We 
then tested Cdt1 localization in PTK2 cells depleted of endogenous Hec1 but expressing 
siRNA-resistant versions of wt Hec1-GFP or Hec1 LoopMUT-GFP. Cdt1 localized to 
kinetochores normally in cells expressing wt Hec1-GFP (Fig. 5c, top panel), but was 
strikingly undetectable at kinetochores in cells expressing Hec1 LoopMUT-GFP (Fig. 5c, 
bottom panel). Orc6 kinetochore targeting was also dependent on the Hec1 loop (Fig. 5d).
HeLa cells expressing only Hec1 LoopMUT-GFP bore striking similarities to Cdt1-depleted 
cells. Only 14% reached late prometaphase while 86% remained in early to mid-
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prometaphase (Figs. 5e and 5f, Movie S6 and Fig. S6b) unlike cells expressing wt Hec1-
GFP (12/13 cells, Movie S5 and Fig. S6a). Live-imaging of cells expressing only Hec1 
LoopMUT-GFP also revealed a 100% mitotic arrest phenotype (n = 29). The phenotypes of 
Hec1 LoopMUT-GFP cells were more severe than Cdt1-depleted cells, which could be due to 
quantitative differences in effectiveness of the different siRNAs in synchronized vs. 
asynchronous cultures, defects in spindle structure from Hec1 perturbation, or to additional 
functions of the loop apart from Cdt1 binding. The range of phenotypes in both 
circumstances was similar however (Fig. S6c and S6d) suggesting that the Hec1 LoopMUT 
phenotype might be largely explained by failure to recruit Cdt1 to kinetochores.
The absence of Cdt1 at kinetochores causes defective kinetochore-MT attachment and 
Mad1-dependent arrest
These phenotypes prompted us to probe the spindle assembly checkpoint status of arrested 
cells. In Cdt1-depleted cells, kinetochore localization of the checkpoint protein, Mad1, was 
5.2-fold higher than in control cells (Fig. 6a, top and middle panel and Fig. 6b). We 
measured a similar 4.5-fold Mad1 increase at aligned kinetochores in cells expressing Hec1 
LoopMUT-GFP vs. wt Hec1-GFP (Fig. 6a, bottom panel and Fig. 6c). Kinetochore 
localization of another checkpoint protein, BubR1, was unaltered by Cdt1 depletion (data 
not shown). To test if Mad1 recruitment fully accounts for the mitotic arrest produced by 
Cdt1 inhibition, we co-depleted Mad1 with Cdt1. As demonstrated previously25, control 
cells depleted of Mad1 alone underwent premature anaphase onset (Fig. 6, compare d and f). 
Importantly, co-depletion of Mad1 with Cdt1 bypassed the mitotic arrest of Cdt1-depleted 
cells (Fig. 6, compare e and g). We thus conclude that Cdt1 depletion induces persistent 
Mad1-dependent spindle assembly checkpoint signaling. Of further note, synchronized cells 
co-depleted of both Mad1 and Cdt1did not produce many anaphase bridges relative to 
Mad1-depleted cells. We reasoned that unreplicated DNA segments would not be segregated 
properly leading to the production of anaphase chromosome bridges. The absence of 
increased anaphase bridges reinforces our assertion that Cdt1 is not required during S phase 
for complete DNA replication. On the other hand, asynchronous cells depleted of either 
Cdt1 or Orc6 produced many anaphase bridges (Fig. S7a and S7b and data not shown).
The presence of high levels of Mad1 at kinetochores suggested that loss of Cdt1 or mutation 
of the Hec1 loop produces kMT (kMT) attachments that are insufficiently robust. We 
therefore tested the cold stability of kMTs by chilling cells at late prometaphase or 
metaphase before fixing them for immunofluorescence. The fluorescence of kMTs after cold 
treatment for Cdt1-depleted cells or Hec1 LoopMUT-GFP cells was ~50% of controls (Fig. 
7a, top and middle panel and Fig. S7c). Quantification of kinetochores that made contact 
with cold-stable spindle MTs revealed a 77% decrease in the number of K-fibers in Cdt1-
depleted cells and an 84% decrease in Hec1 LoopMUT-GFP cells relative to corresponding 
controls (Fig. 7b). As an additional indicator of kMT attachment, we measured the inter-
kinetochore stretch (K-K) distance of aligned sister kinetochore pairs; ~1.4 μm for siRNA-
transfected controls and ~1.25 μm for Hec1-depleted cells expressing wt Hec1-GFP. In 
contrast, the K-K distance was just 0.96 μm in Cdt1-depleted cells and 1.05 μm in cells 
expressing Hec1 LoopMUT-GFP (Fig. 7c). These values correspond to a 50–60% loss of 
kinetochore stretch since the unstretched K-K centromere length is ~0.7 μm in cells treated 
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with nocodazole26. As in Cdt1-depleted cells, there were no discernible changes in the 
kinetochore localization of most other proteins tested in cells expressing Hec1 LoopMUT-
GFP (Fig. S8b).
To determine if artificially strengthening MT attachments can compensate for Cdt1 loss or 
mutations in the Hec1 loop domain, we blocked Aurora B kinase-mediated Hec1 
phosphorylation. Pharmacological Aurora B inhibition or mutation of the 9 phosphorylation 
sites in the N-terminal Hec1 tail enhances MT binding affinity at this end of the Ndc80 
complex1, 2, 27–30. Treating Cdt1-depleted mitotic cells with the Aurora B inhibitor, 
ZM447439, caused premature anaphase onset similar to control drug-treated cells or Mad1-
depleted cells, demonstrating effective Aurora B inhibition (Fig. S7f and S7g). We also 
coupled our synchronization and Cdt1 depletion protocol with expression of the Aurora B-
resistant Hec1 (9A-Hec1-GFP) combined with endogenous Hec1 depletion. The result of 
this manipulation was identical to that of Aurora B inhibition (data not shown). To test if 
progression to anaphase in these experiments involved stabilization of kMT attachments, we 
treated cells with the proteasome inhibitor, MG132, to prevent anaphase onset and subjected 
them to the cold stability assay. ZM447439-treated or 9A-Hec1-GFP-expressing cells 
lacking Cdt1 retained stable kMTs (Fig 7d and 7e). These results indicated that the absence 
of Cdt1 at kinetochores results in failure to establish and/or maintain sufficiently strong 
kMT attachments.
Interaction of Cdt1 with the Hec1 loop is required for the normal conformation of the 
Ndc80 complex at kinetochores of bi-oriented chromosomes
The loop region of Hec1 allows conformational changes within the Ndc80 complex3. To 
determine if Cdt1 influences this conformation, we employed an in vivo two-colour super 
resolution fluorescence microscopy technique by labeling the two ends of the Ndc80 
complex (Delta analysis illustrated in Fig. 8a26). We used the 9G3 antibody whose epitope 
in Hec1 resides next to the N-terminal CH domain, an anti-Spc24 antibody to mark the C-
terminal region of the Ndc80 complex, and a Nsl1 antibody to mark the Mis12 complex, 
which is about 4 nm inside Spc2426 (Fig. 8a). Measurements of the average separation, 
Delta, between 9G3 and the two other antibodies yielded values of ~41 and ~45 nm for 
kinetochores of aligned chromosomes in control cells at metaphase (Figs. 8c and 8d). After 
Cdt1 depletion, the corresponding Deltas were ~35 nm and ~37 nm respectively (Figs. 8c–
d), values significantly different from controls (p<0.001). To determine if these reductions 
were a general consequence of unstable kMT attachments, we measured Delta following 
depletion of Rod (a component of the RZZ complex) which, like Cdt1 depletion, produces 
50% reduction in kMT stability31. Unlike Cdt1 depletion, Delta values for Rod depletion 
(~39 nm and ~45 nm, Fig. 8c–d) were not significantly different from controls (p= 0.31 and 
p = 0.86 respectively); Rod-depletion reduced K-K stretch from ~1.4 μm to 1.15 μm 
demonstrating the effectiveness of the siRNA. In nocodazole-treated cells which lack kMTs, 
the distance between the ends of the Ndc80 complex along the K-K axis is short with a Delta 
value of ~ 17 nm28. We measured Delta values for Cdt1-depleted and nocodazole-treated 
cells at 19 +/− 7 nm for Spc24-9G3 and 20 nm +/−8 nm for Nsl-9G3 (n =100 sister 
kinetochore pairs, > 5 cells). Taken together, these results suggest that the essential mitotic 
function of Cdt1 is to bind to the Ndc80 complex at the Hec1 loop and maintain an extended 
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conformation along the lattice of kMTs to stabilize end-on attachments of spindle MTs to 
kinetochores.
Discussion
Distinct essential functions for Cdt1 in both G1 and M phases
Using a unique approach to deplete Cdt1 specifically after its replication function is 
completed, we unequivocally demonstrated an essential and previously unknown mitotic 
function for human Cdt1 in kMT attachment. This discovery raises the question of why such 
dual roles would have evolved. One possibility is to ensure orderly progression from S phase 
to M phase. Cdt1 is degraded while replication is ongoing to avoid re-licensing origins that 
have already fired 32, 33. We recently reported a mechanism of Cdt1 stabilisation after S 
phase through MAP kinase-mediated phosphorylation18. We now suggest that Cdt1 
stabilisation in G2 cells evolved to facilitate its rapid re-accumulation prior to mitosis. 
Though yeast Cdt1 is clearly not required for anaphase34, 35, metazoan Cdt1 may have 
acquired its mitotic role as a means of reinforcing the dependence of a key mitotic event on 
the completion of genome duplication. The acquisition of functions in two different cell 
cycle phases has the consequence that deregulation of Cdt1 has the potential to affect both 
origin licensing and mitosis, and thus genome stability36, 37.
The role of the Hec1 “loop” domain
The presence of high levels of Mad1 at kinetochores of Cdt1-depleted cells or Hec1 
LoopMUT–expressing cells indicates that Cdt1 and the loop are required for attachment but 
not for Mad1 retention, unlike cells lacking Hec1 entirely in which both attachment and 
Mad1 retention are defective (28, 29; data not shown). The globular CH domain and N-
terminal tail of Hec1 make direct contacts with MTs, and the loop domain is not required for 
high affinity binding of Ndc80bonsai complexes to MTs, a construct lacking the region that 
includes the loop38. It was therefore somewhat surprising that mutation of the Hec1 loop 
domain, a site ~18 nm along the Hec1 rod domain from these direct MT contacts, had such 
profound negative effects on the formation of stable MT attachments. Clearly the formation 
of robust attachments in vivo requires not only the Hec1 CH domain and N-terminal region, 
but also Cdt1 interaction with the loop domain.
Recent studies in yeast have shown a requirement for the loop in yeast Hec1/Ndc80 for 
binding MT binding proteins (MAPs), i.e. the Dam1 complex in budding yeast or Dis1/TOG 
in fission yeast4, 5. The amino acid sequence of the loop is not highly-conserved3, and 
human Cdt1 has no detectable sequence homology to Dam1 complex members or to Dis/
TOG. Nevertheless, Cdt1 could serve an analogous function by interacting with MTs or an 
as yet, unidentified MT-associated protein (Fig. 8e) or alternatively by silencing Aurora B-
mediated k-fiber destabilisation.
A model for Cdt1-Hec1 interaction in mitosis
The Hec1 loop produces a flexible hinge in the otherwise relatively rigid Ndc80 complex. In 
the complete absence of MTs, the average separation, Delta, between the two ends of the 
Ndc80 complex is only ~19 nm26 in both controls and Cdt1-depleted cells. This average 
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distance extends to ~41 nm for control metaphase cells when kinetochores achieve a full MT 
complement. In the absence of Cdt1, Ndc80 does not make this full extension producing 
Delta measurements ~68 – 76% between the two extremes. In contrast, Rod depletion 
removes the major recruitment factor for the dynein-dynactin complex and disrupts other 
kMT-binding sites contributed by this MT motor31, 39, 40. The fact that Ndc80 can adopt the 
full extended shape in Rod-depleted cells which, like Cdt1-depleted cells, have unstable 
kMT attachments31 argues against a general indirect effect of attachment on Ndc80 
conformation. We propose that Cdt1 physically links the Hec1 loop to the MT or a MT-
associated protein, and this additional attachment stabilises the extended conformation and 
enhances the MT affinity of the Ndc80 complex provided by the Hec1 CH domain and N-
terminal tail.
Methods
Cell culture, transfection and flow cytometry
HeLa (normal and stably expressing Histone H2B) and NHF1-htert cells were cultured in 
DMEM (Difco or Invitrogen) supplemented with 10% fetal bovine or calf serum (Sigma), 
100 U/ml penicillin and 100 mg/ml streptomycin. LLCPK1 cells were grown in DMEM 
with 5% FBS while PTK2 cells were cultured in MEM-alpha medium supplemented with 
15% FBS. Transfections were performed with a total of 100 nM each siRNA duplex using 
Dharmafect 1 reagent (Dharmacon/Thermo Scientific, Lafayette, CO, U.S.A.) according to 
the manufacturer’s guidelines. Stable cell lines expressing Cdt1 have been described18. Flow 
cytometric analysis for cell cycle position was performed as in Nevis et. al., 200916. 
Synthetic siRNAs: si-cdt1 and si-cdc616 were synthesized by Invitrogen/Life Technologies 
(Carlsbad, CA, U.S.A.), si-mad1 was purchased from Dharmacon (SMART pool catalog 
#L-005825-00-0005), si-rod from Dharmacon (SMARTpool catalog #L006829-00-0005), 
si-hec1(human)28 5′-AAAAAGAACCGAAUCGUCUAGAA, si-hec1 (rat kangaroo) 5′ 
AAUGAGCCGAAUCGUCUAAUAdTdT, and si-orc614= 
AAGAUUGGACAGCAGGUCGACUU were synthesized by Dharmacon.
HeLa cells were synchronized by treatment with 2 mM thymidine for 18 hours followed by 
release for 9 hours and then re-treatment with 2 mM thymidine for 18 hours. Synthetic 
duplexed RNA oligonucleotides were s transfected into HeLa cells using the manufacturer’s 
instructions. Other cell manipulations include 10 μM nocodazole treatment, 3 μM 
ZM447439 treatment and cold treatment for 10 min with ice-cold PBS.
Antibodies
Guinea pig anti-Cdt1 is described in41 (diluted 1:3000 for immunoblots and 1:100 for 
immunofluorescence staining); rabbit polyclonal anti-Cdt1 was purchased from Santa Cruz 
Biotechnology, Santa Cruz, CA, U.S.A. (catalog # sc28262). Other primary antibodies used 
in this study include anti-Tubulin monoclonal (1:20,000 for immunoblots and 1:500 for cell 
staining, Sigma-Aldrich, St. Louis, MO, U.S.A. #9026, clone [DM1A]), anti-Dynein IC 
monoclonal antibodies (1:200 for staining Sigma-Aldrich, # D5167, clone [70.1]), anti-Hec1 
(1:6,000 for immunoblots and 1:500 for staining, Abcam, Cambridge, MA, U.S.A. #ab3613, 
clone [9G3]), Nuf2 (1:5,000 for immunoblots and 1:200 for staining, Abcam #ab17058, 
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clone [28–37]), anti-GFP polyclonal (1:200 for staining, Invitrogen #A6455), monoclonal 
(1:100 for staining, Chemicon/Millipore, Billerica, MA, U.S.A., #MAB3580) or monoclonal 
(1:5,000 for immunoblots, Clontech, Mountain View, CA, U.S.A. #632381, clone [JL-8]), 
anti-Cdc6 monoclonal (1:1,000 for immunoblots Santa Cruz Biotechnology #sc-9964 clone 
[180.2]), anti-geminin polyclonal (1:200 for staining, Santa Cruz Biotechnology #sc-13015), 
anti-phospho-H2A.X(Ser139) (1:1000 for staining, Millipore #05-636, clone [JBW301]), 
anti-Mad1 polyclonal (GeneTex, Irvine, CA, U.S.A. #GTX109519). Alexa 488, Rhodamine 
Red-X, Cy5 or HRP-labeled secondary antibodies were obtained from Jackson 
ImmunoResearch, West Grove, PA, U.S.A. Orc6 polyclonal antibody (1:200) for staining 
was a generous gift of Bruce Stillman; anti-Orc6 for immunoblots (1:1000) was purchased 
from Santa Cruz Biotechnology (# sc-32735, clone [3A4]). Immunoblots were scanned into 
Adobe Photoshop and any manipulations for brightness were applied to the entire image; 
final figures show cropped regions and the uncropped blots are provided as Supplementary 
Figure S9.
Immunofluorescence microscopy, live cell imaging, and Delta analysis
Cells were typically fixed for 20 min using 4% paraformaldehyde after permeabilisation 
with 0.5% Triton X-100. For Spc24 staining, 2% PFA was used. For Dynein IC staining, the 
cells were fixed for 6 min at −20°C with ice-cold methanol. Cells were rinsed in PHEM 
buffer (120 mM Pipes, 50mM HEPES, 20 mM EGTA, 4 mM magnesium acetate, pH 6.9) 
prior to fixation. All the antibody incubations and washes were also performed in PHEM 
buffer plus 0.05% BSA. DAPI staining (0.1 μg/ml) was for 10 min, and cells were mounted 
using Prolong Antifade (Molecular Probes). All antibody incubations were conducted at 
37°C for 1 h. For image acquisition, 3D stacks were obtained sequentially at 200 nm steps 
along the z axis through the cell using a high-resolution Nikon confocal microscopy 
equipped with a Yokogawa CSU10 spinning disk with image magnification yielding a 65 
nm pixel size from the camera42 and an 100X/1.4NA (Planapo) DIC oil immersion objective 
(Nikon). Scale bars = 5 μm in all figures and supplementary figures unless otherwise defined 
in the figure legends. Delta analysis to measure separations at high (nm) accuracy between 
protein epitopes labeled with separate colours were carried out as described in Wan et al., 
200926.
For microinjection, polyclonal anti-Cdt1 antiserum41 was depleted of antibodies to non-Cdt1 
proteins by repeated rounds of incubation with lysates of UV-treated HeLa cells (which lack 
Cdt1). These antibody preparations were then concentrated by centrifugation using 
microconcentrators. Anti-Cdt1 antibody, control IgG, or buffer were injected into HeLa cells 
that stably express a GFP-fusion to histone H2B either in prometaphase or in metaphase. 
Injections were carried out on a Zeiss IM microscope equipped with phase optics and a 40x, 
0.75 NA (Planfluar) objective at 35°C using a Sage air curtain incubator. Injections were 5% 
cell volume with a Narishige micromanipulator (Narishige USA, Inc., Sea Cliff, New York). 
Mitotic progression was monitored by live-cell imaging using both phase contrast and GFP-
histone H2B fluorescence with images acquired every two minutes until the end of the 
duration of imaging.
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For live imaging of Hec1-depleted cells, HeLa cells were plated to 50% confluency in a T25 
flask and treated with siRNA to Hec1. 24 hrs post-siRNA transfection, cells were 
trypsinized, counted, and the Hec1 wt and mutant constructs were electroporated along with 
mCherry-histone H2B expression plasmid using the Lonza Nucleofector apparatus. 24 hours 
post-electroporation, cells were imaged by time-lapse microscopy every 4 minutes for 5 hrs 
using a Deltavision PersonalDV Imaging System (Applied Precision) equipped with a 
Photometrics CoolSnap HQ2 camera and a 60x/1.42NA (Planapo) DIC oil immersion lens 
(Olympus).
Protein-protein interaction assays
For two-hybrid screening, the full-length human Cdt1 cDNA was inserted into pGBT9 
(Clontech). Co-transformants of yeast strain PJ69a43 with two cDNA fusion libraries 
(placental cDNA or thymus cDNA, Clontech) were selected on medium containing 10 mM 
3-amino-1,2,4 triazole (Sigma). More than 8 million co-transformants of each library were 
screened; Hec1 clones were identified from both libraries. GST-pulldowns and co-
immunoprecipitations were performed essentially as described in Cook et al. 200441. GST-
Cdt1 was produced in BL21(DE3) purified on glutathione-Sepharose (GE Healthcare) and 
incubated with cell lysates prepared in Buffer 1 (50 mM HEPES pH 7.2, 33 mM potassium 
acetate, 0.5 mM EDTA, 0.5 mM EGTA, 0.1 % Nonidet P-40, 10% glycerol, protease and 
phosphatase inhibitors). Cell lysates were prepared in Buffer 1 or a 1:1 mix of Buffer 1 and 
CSK Buffer (10 mM PIPES, pH 7.0, 100 mM NaCl, 30 0mM sucrose, 3 mM MgCl2 plus 
protease and phosphatase inhibitors) digested with micrococcal nuclease prior to 
clarification by centrifugation, and incubated with GST protein-coated beads for 2 hours, or 
with antibodies for co-immunoprecipitation and protein A beads, washed three times, and 
then released by boiling in SDS-PAGE loading buffer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cells depleted of Cdt1 after S phase do not complete cell division
(a) Normal human fibroblasts (NHF1-htert) were transfected with siRNAs targeting cdc6, 
cdt1, or GFP (control) mRNAs for 72 hours. Cells were labeled with BrdU for the final hour 
and then analysed by flow cytometry for cell cycle position and by immunoblotting for 
endogenous Cdc6, Cdt1, and Tubulin. (b) Diagram of experimental design. Endogenous 
Cdt1 protein levels normally drop during S phase due to ubiquitin-mediated proteolysis and 
recover beginning in G2 (dotted gray line). Release from an early S block into cdt1 siRNA 
transfection medium blocks Cdt1 protein re-accumulation (solid gray line). (c) Immunoblot 
analysis of endogenous Cdt1 protein in cells synchronized as diagrammed in b; M phase 
occurs between 9 and 10 hours post-release from the second thymidine arrest. (d) Stable 
HeLa cell lines transduced with empty vector (lanes 1–4) or an siRNA-resistant form of 
Cdt1 (“Cdt1res” lanes 5 and 6) were synchronized as in b and transfected with either control 
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siRNA targeting GFP (lanes 1 and 2) or with cdt1 siRNA (lanes 3–6). Cells were released 
from early S phase into nocodazole for 10 hr and then either harvested (0 hr) or released for 
2 hours into G1 phase, and Cdt1 protein levels were analysed by immunoblotting. (e) Flow 
cytometric analysis of DNA content of cells in d.
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Figure 2. G2-specific Cdt1 inhibition induces mitotic arrest
(a) HeLa cells synchronized in early S phase were released into control (luciferase) or cdt1 
siRNA for either 9 hrs (top and middle panels) or 10 hrs (bottom panels) followed by 
fixation and staining with DAPI to label chromosomes (blue), anti-tubulin antibody to label 
MTs (red), and anti-Knl1 antibody to label kinetochores (green). (b) Quantification of the 
results at 10 hr in a by mitotic stage; n = 1500 cells. (c–e) HeLa cells stably expressing GFP-
histone H2B were injected with control buffer (c, n=15) or anti-Cdt1 antibody (d, n=27). 
Selected frames of GFP-histone (top panels) and phase contrast images (bottom panels) are 
shown. (e) Quantification of the results from the microinjection experiments in c and d. 
Scale bars = 5 μm. See also Supplementary Movies S1–S4.
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Figure 3. Cdt1 transiently localizes to kinetochores during prometaphase and metaphase
(a) Nocodazole-treated PTK2 cells were immunostained with anti-Cdt1 antibody and anti-
Hec1 antibody. (b–f) LLCPK1 cells at different stages of mitosis were immunostained with 
anti-Cdt1 antibody and anti-Hec1 antibody. Scale bars = 5 μm.
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Figure 4. Hec1 is required for Cdt1 kinetochore localization
(a) A lysate of T98G (human glioblastoma) cells was incubated with beads coated with 
bacterially-produced GST or GST-Cdt1, and the endogenous Hec1 and Nuf2 were detected 
in the input or bound fractions by immunoblotting. (b) Whole cell lysates of HeLa cells 
were incubated with pre-immune serum or anti-Cdt1 antibody, and endogenous Hec1 was 
detected in the input and immunecomplexes. (ND: Cdt1 co-migrates too closely to IgG 
heavy chain for detection in this IP.) (c) Whole cell lysates of HeLa cells were incubated 
with control serum or anti-Hec1 antibody; endogenous Cdt1 and Hec1 were detected in the 
input and immunecomplexes. (d) Nocodazole-treated PTK2 cells subjected to hec1 RNAi 
were fixed and stained with anti-Cdt1 antibody and anti-ACA antibody to mark 
kinetochores. (e) Quantification of Cdt1 kinetochore fluorescence intensity in d relative to 
control luciferase siRNA transfected cells; n = 80 kinetochores; p < 0.01. (f) HeLa cells 
were treated with control luciferase siRNA or hec1 siRNA, fixed and stained using anti-
Orc6 antibody, anti-Hec1 antibody to monitor the Hec1 knockdown, and anti-ACA antibody 
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to label kinetochores. (g) Quantification of Orc6 kinetochore fluorescence intensity in f 
relative to control luciferase siRNA transfected cells; n = 125 kinetochores; p < 0.01. Scale 
bars = 5 μm.
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Figure 5. Cdt1 targeting to kinetochores depends on the flexible loop region of Hec1
(a) Diagram of the Ndc80 complex showing the loop region and the construction of the 
Hec1 loop replacement mutant,“Hec1 LoopMUT”, (adapted from Ciferri et al., 200835). (b) 
Endogenous Cdt1 was immunoprecipitated from lysates of asynchronously growing HeLa 
cells transfected with Hec1-GFP plasmids; “Ctrl IP” indicates the use of normal mouse 
serum as a control. Hec1-GFP in the bound (“Cdt1 IP”) and unbound (“Supe.”) fractions 
was detected with anti-GFP antibody. (c) PTK2 cells were treated with hec1 siRNA 
followed by transfection with either wt Hec1-GFP or Hec1 LoopMUT-GFP constructs. The 
cells were treated with nocodazole then fixed and stained using anti-Cdt1 antibody and anti-
GFP antibody. (d) As in c except that HeLa cells were stained with anti-Orc6 and anti-GFP 
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antibodies. (e) As in c except that HeLa cells were stained with anti-tubulin antibody to 
mark MTs and anti-GFP antibody to mark Hec1-GFP at kinetochores. (f) Quantification of 
mitotic stages in Hec1-depleted cells expressing ectopic wt Hec1-GFP or Hec1 LoopMUT-
GFP stained with DAPI; n = 125 GFP-expressing cells. Scale bars = 5 μm. See also 
Supplementary Figure S8 and Supplementary Movies S5 and S6.
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Figure 6. Cdt1 and the Hec1 Loopdomain are required to satisfy the spindleassembly checkpoint
(a) Top and middle panel: Cdt1-depleted or control cells as in Fig. 2b (10 hrs after 
thymidine release). Bottom panel: Hec1-depleted cells expressing siRNA-resistant Hec1 
LoopMUT –GFP. Cells were fixed and stained with antibodies to Mad1 to assess spindle 
assembly checkpoint activity and Knl1 to mark kinetochores. (b) Quantification of Mad1 
kinetochore levels in mitotic cells treated with control or cdt1 siRNA; n = 125 kinetochores; 
p < 0.01. (c) Quantification of Mad1 levels in mitotic cells expressing Hec1 wt or LoopMUT 
constructs instead of endogenous Hec1; n = 150 kinetochores; p < 0.01. (d–g) Double 
thymidine synchronized HeLa cells were transfected with control luciferase siRNA (d), cdt1 
siRNA (e), mad1 siRNA (f) and a combination of both cdt1 and mad1 siRNA (g) and then 
stained with DAPI (pseudo-coloured red) and anti-tubulin antibody (green) at 9 hrs or 10 hrs 
after S phase release.
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Figure 7. Cdt1 and the Hec1 Loopdomain are required for stable kMT attachments
(a) Control cells in metaphase, Cdt1-depleted cells, and cells expressing Hec1 LoopMUT (in 
place of endogenous Hec1) in late prometaphase were incubated with ice-cold PBS (which 
allows retention of only stable kMTs) followed by fixation and staining with anti-tubulin 
antibody (MT) and either anti-Bub1 antibody to mark the kinetochores or anti-GFP antibody 
for ectopic Hec1 as indicated. (b) Quantification of the fraction of kinetochores making 
successful contact with K-fibers in Cdt1-depleted or Hec1 LoopMUT cells; n = 250 
kinetochores (c) Inter-kinetochore (K-K) distances in the indicated cells; n = 100–125 
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kinetochores; p < 0.01. (d) Synchronized HeLa cells treated with either control luciferase or 
cdt1 siRNA as indicated were treated with both ZM447439 (Aurora B inhibitor) and MG132 
(anaphase inhibitor) for hr at 8.5 hrs post-S phase release followed by cold treatment and 
staining with anti-tubulin antibody and anti-Knl1 antibody. (e) Synchronized HeLa cells 
were co-transfected with both hec1 siRNA and either a plasmid encoding 
unphosphorylatable 9A-Hec1- GFP (top panels) followed by MG132 treatment for hr at 8.5 
hrs post S phase release or plasmid encoding Hec1 LoopMUT-GFP (bottom panel). The cells 
were then subjected to cold treatment at 9 hrs post-S phase release and stained with anti-
tubulin antibody and anti-GFP antibody. Scale bars = 5 μm.
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Figure 8. Cdt1 and the Hec1 loop domain are required for proper Ndc80 conformation in vivo
(a) Diagram of the Ndc80 complex depicting the antibody epitopes used for the Delta 
analysis. (b) Representative image of a normal mitotic metaphase cell labeled with 
antibodies to the Hec1 CH domain and the Spc24 head domain. Scale bar = 1 μm. (c) Delta 
values (corrected for tilt28) of mean separation between Spc24 and the Hec1 CH domain 
(9G3 antibody) in synchronized control or Cdt1-depleted mitotic cells (9 hrs after S phase 
release), or in Rod-depleted cells (mitotic metaphase cells selected from an asynchronous 
population); n = 84, 47, and 54 kinetochore pairs respectively; (control vs. si-cdt1) p < 
0.001, (control vs. si-rod) p=0.31 (not significant). (d). As in c except that Delta values of 
separation between Nsl1 (Mis12 complex subunit) and the Hec1 CH domain were 
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determined; n = 74, 41, and 60 kinetochore pairs respectively; (control vs. si-cdt1) p < 0.001, 
(control vs. si-rod) p = 0.86 (not significant). (e) Scale model for the Cdt1-Hec1 Loop 
domain interaction.
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